Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
About this item
Full title
Author / Creator
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Pitavastatin is a potent HMG-CoA reductase inhibitor and efficient hepatocyte low-density lipoprotein cholesterol (LDL-C) receptor inducer, producing robust reduction of the serum LDL-C levels, even at a low dose. Pitavastatin and its lactone form are minimally metabolized by CYP enzymes, and are therefore associated with minimal drug-drug interact...
Alternative Titles
Full title
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7c7e784b2ab54af7b609e43bc235dac2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7c7e784b2ab54af7b609e43bc235dac2
Other Identifiers
ISSN
1178-2048,1176-6344
E-ISSN
1178-2048
DOI
10.2147/VHRM.S5551
